Dr. Paul Fishkin

Hematology | Oncology
8940 N Wood Sage Rd, 
Peoria, IL 
Offers Telehealth
8940 N Wood Sage Rd, 
Peoria, IL 
OverviewInsuranceLocationsClinical Research

Overview

Paul Fishkin is a Hematologist and an Oncologist in Peoria, Illinois. Dr. Fishkin is rated as an Experienced provider by MediFind in the treatment of Prothrombin Deficiency. His top areas of expertise are Lung Cancer, Agranulocytosis, Pleuropulmonary Blastoma, Severe Congenital Neutropenia, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Oncology
Licenses
Internal Medicine in IL
Hospital Affiliations
Graham Hospital Association
Mason District Hospital
Methodist Medical Center Of Illinois
St Mary Medical Center
Saint Francis Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

ONCOLOGY-HEMATOLOGY ASSOCIATES OF CENTRAL ILLINOIS P C
8940 N Wood Sage Rd, Peoria, IL 61615

Additional Areas of Focus

Dr. Fishkin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Enrollment Status: Completed
Publish Date: October 19, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 3

12 Total Publications

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.
Journal: Blood advances
Published: May 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fishkin's expertise for a condition
ConditionClose
    View All 20 Distinguished Conditions
    View All 69 Advanced Conditions
    View All 127 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile